Clinical Trials
12 trialsNCT03594630 2026-05-20
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05108428 2026-04-01
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT05245786 2025-11-10
An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06931873 2025-04-17
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
Changhai Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT04213794 2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1 Terminated
NCT05759741 2023-03-14
Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy
Huashan Hospital
Phase EARLY_PHASE1 Unknown
NCT03280277 2021-09-10
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Terminated
NCT00091286 2020-03-30
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
University of Virginia
Phase EARLY_PHASE1 Terminated
NCT00835679 2014-05-23
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated
NCT01403103 2014-01-17
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT00436410 2012-05-02
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed